The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 13, 2016
Filed:
Nov. 01, 2012
Applicants:
Yaohuang KE, San Francisco, CA (US);
Sum Wai Pierre Lee, San Francisco, CA (US);
Yongke Zhang, Palo Alto, CA (US);
Guo-liang Yu, Hillsborough, CA (US);
Weimin Zhu, Millbrae, CA (US);
Inventors:
Yaohuang Ke, San Francisco, CA (US);
Sum Wai Pierre Lee, San Francisco, CA (US);
Yongke Zhang, Palo Alto, CA (US);
Guo-Liang Yu, Hillsborough, CA (US);
Weimin Zhu, Millbrae, CA (US);
Assignee:
Apexigen, Inc., Burlingame, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 14/71 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); C07K 14/71 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01);
Abstract
The present invention provides anti-KDR monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of a variety of cancers, rheumatoid arthritis, diabetic retinopathy and other diseases associated with aberrant VEGF or KDR expression and/or activity.